CClinicalTrials.gg
CompletedNCT06025526Updated Oct 9, 2024

Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot)

An interventional study of aktivplan and Usual care in Cardiac Rehabilitation, Secondary Prevention and Cardiovascular Diseases, sponsored by Ludwig Boltzmann Institute for Digital Health and Prevention. Completed at 2 sites in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-09.

Sponsored by Ludwig Boltzmann Institute for Digital Health and Prevention · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical pilot / feasibility study is to determine the feasibility of conducting a large-scale clinical effectiveness trial of the aktivplan digital intervention in cardiac rehabilitation patients.

The main questions this study aims to answer are:

  • Is it feasible to conduct a large-scale (fully powered) effectiveness trial of the aktivplan digital intervention?
  • What is the usability, user experience and user acceptance of the aktivplan digital intervention?

Patients enrolled in a phase II cardiac rehabilitation programme will be randomly allocated to either the intervention group (aktivplan digital intervention) ot the usual care control group and followed-up for 10 weeks after discharge from cardiac rehabilitation.

Patients in the intervention group will be given the aktivplan application (app) on their smartphone. A rehabilitation professional will plan a personalised heart-healthy physical activity plan together with the patient and enter it to the aktivplan app. The patient will be asked to follow their personal physical activity plan for 10 weeks, using the aktivplan app to document completed physical activity sessions.

Patients in the control group will receive the usual standard of care without the aktivplan digital intervention.

Researchers will analyse information such as the rate of recruitment, participant attrition, data completeness and technical stability of the app to determine the feasibility of conducting a large-scale clinical effectiveness trial.

02

Conditions studied

  • Cardiac Rehabilitation
  • Secondary Prevention
  • Cardiovascular Diseases

Keywords

  • Digital Health
  • Mobile Health
  • Electronic health
  • Smartphone App
03

In context

Cardiovascular Diseases

4,904 studies on the registry are indexed under Cardiovascular Diseases; 919 are open to participants now.

This study's enrollment of 34 is below the median of 100 across 2,738 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Ludwig Boltzmann Institute for Digital Health and Prevention is the lead sponsor of 7 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Enrollment to a cardiac rehabilitation programme phase II, or a rehabilitation programme phase II due to non-cardiac indication but displaying cardiovascular risk factors
  • Ownership and use of a smartphone compatible with the aktivplan digital intervention and with internet connection
  • Agreement to attend the study follow-up visit
  • Written informed consent to take part in the study

Exclusion criteria

Exclusion Criteria:

  • Existing use of a digital intervention for regular heart-healthy physical activity
  • Medical contraindications for incremental cycle ergometry test
  • Medical contraindications for regular heart-healthy physical activity and sports
  • Medical contraindications for use of a smartphone
  • Inability to carry out cardiovascular training (e.g., due to significant musculoskeletal restrictions)
  • Participation in another clinical study within the past 6 months
  • Addiction or other medical conditions causing reduced decisional capacity
  • Pregnant women in the third trimester
  • Pregnant women in the first and second trimester with medical contraindication for physical activity and sports
  • Breastfeeding women with medical contraindication for physical activity and sports
  • Indication that patient is unlikely to follow study procedures (limited cooperation)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Intervention

    Other: aktivplan

  • Other
    Control

    Other: Usual care

Interventions

  • Otheraktivplan

    The aktivplan digital intervention consists of a digital planning calendar for regular heart-healthy physical activity Towards the end of rehabilitation phase II, health professionals introduce aktivplan and plan a personalised physical activity plan together with their patients using shared decision-making. The physical activity plan is devised for the time after discharge from cardiac rehabilitation. In the aktivplan smatphone app, the patient can view their personalised physical activity plan, check off completed activities, enter additional unplanned activities, and open short videos with exercise instructions. Additional functions of aktivplan include patient-centered goal-setting, automated messages to the patient (motivational messages and reminders), and the possibility for health professionals to monitor all their patients' adherence to the physical activity plan and to contact individual patients directly via the app.

  • OtherUsual care

    Usual care (standard of care) according to international and national cardiac rehabilitation guidelines.

06

What researchers measure

Primary outcomes

  1. Recruitment rate

    Number of recruits per week

    Time frame: 10 weeks

  2. Drop-out rate

    Number of drop-outs in at the 10-week follow-up visit

    Time frame: 10 weeks

  3. Data completeness

    Percentage of missing data fields in the study database

    Time frame: 10 weeks

  4. Adherence to the aktivplan digital intervention

    Automated usage logging of the aktivplan mobile application (Matomo platform)

    Time frame: 10 weeks

  5. Usability of the aktivplan digital intervention

    mHealth App Usability Questionnaire (MAUQ)

    Time frame: 10 weeks

  6. User experience of the aktivplan digital intervention

    AttrakDiff Short Questionnaire

    Time frame: 10 weeks

  7. User acceptance of the aktivplan digital intervention

    Mobile Application Rating Scale (MARS)

    Time frame: 10 weeks

  8. Technical stability of the aktivplan digital intervention

    Number and types of technical problems (qualitative data)

    Time frame: 10 weeks

  9. Use of alternative and additional strategies for supporting physical activity

    Number and types of additional strategies (qualitative data)

    Time frame: 10 weeks

  10. Experiences and perspectives of patients regarding their study participation

    Qualitative data from semi-structured interviews

    Time frame: 10 weeks

  11. Experiences and perspectives of rehabilitation professionals regarding the intervention and study procedures

    Qualitative data from focus groups

    Time frame: 10 weeks

Secondary outcomes

  1. Exercise capacity

    Incremental cycle ergometry test

    Time frame: 10 weeks

  2. Physical activity behaviour

    Moderate to vigorous physical activity (MVPA)

    Time frame: 10 weeks

  3. Weight

    Weight in kg

    Time frame: 10 weeks

  4. Blood pressure

    Blood pressure in mmHg

    Time frame: 10 weeks

  5. Blood cholesterol

    Total cholesterol, HDL-cholesterol, non-HDL-cholesterol, total cholesterol / HDL-cholesterol ratio

    Time frame: 10 weeks

  6. HbA1c

    HbA1c level

    Time frame: 10 weeks

  7. Smoking

    Number and type of smoking products per week (qualitative data)

    Time frame: 10 weeks

  8. Health-related quality of life

    EQ-5D-5L Questionnaire

    Time frame: 10 weeks

  9. Exercise self-efficacy

    Exercise Self-Efficacy Scale (ESES)

    Time frame: 10 weeks

  10. Patient safety

    Adverse events reporting (number and severity of adverse events) assessed by the Medical Device Coordination Group (MDCG) form

    Time frame: 10 weeks

07

Study locations

2 sites
  • Reha-Klinik Montafon
    Schruns, Vorarlberg 6780, Austria
  • REHA Zentrum Salzburg
    Salzburg, 5020, Austria
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06025526
Lead sponsor
Ludwig Boltzmann Institute for Digital Health and Prevention
Collaborators
REHA Zentrum Salzburg, Reha-Klinik Montafon
Responsible party
Sponsor
First posted
Sep 6, 2023
Start date
Oct 2, 2023
Primary completion
Jul 29, 2024
Completion
Aug 31, 2024
Last update
Oct 9, 2024

Study contacts

Stefan T Kulnik, PhD MRes
study chair · Ludwig Boltzmann Institute for Digital Health and Prevention

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion